NVAX NOVAVAX INC US FDA Inspections 8-K Filing 2025 - FDA Application Update On April 1, 2025, Novavax confirmed that they submitted their Biologics License Application for their COVID-19 Vaccine to the FDA and are awaiting approval after responding to all information requests. They believe their vaccine is a safe and effective alternative to mRNA vaccines.Get access to all SEC 8-K filings of the NOVAVAX INC